“These results establish the CssDNA process as an efficient non-viral gene insertion strategy, and mark a pivotal advance towards the development of next-generation cell and gene therapies” said ...
YolTech Therapeutics, a clinical-stage biotechnology company developing next-generation in vivo gene editing therapies, today announced that the U.S. Food and Drug Administration (FDA) has cleared the ...
The inventor of base and prime editing shares insights on medicine's efforts to make serious genetic diseases treatable or ...
Explore CRISPR technology explained, gene editing science, DNA modification, and genetic engineering ethics—discover how ...
CSIR-IGIB and Serum Institute of India sign a tech transfer pact to develop an indigenous, affordable CRISPR-based ...
An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, ...
In a highly anticipated article, FDA officials Vinay Prasad, M.D., and Martin Makary, M.D., outlined a novel regulatory ...
In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the ...
A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects ...
Genetic manipulation – or gene editing – is a concept that describes altering the genetic material (DNA) of an organism.
An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.
A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback